Anne Oriordan
Director, Jazz Pharmaceuticals.
Companies
- Jazz PharmaceuticalsBoard member Feb 21, 2019 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Jazz Pharmaceuticals JAZZ16,500 shares2$3.4M at $207.05Aug 8, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 8, 2025Shares withheld for tax 1,805 shares at $111.25 of Jazz Pharmaceuticals2
- Aug 7, 2025Granted 3,507 shares of Jazz Pharmaceuticals2
- Aug 6, 2024Shares withheld for tax 1,484 shares at $111.35 of Jazz Pharmaceuticals3
- Aug 2, 2024Granted 3,731 shares of Jazz Pharmaceuticals3
- Aug 14, 2023Sold 1,241 shares at $138.16 of Jazz Pharmaceuticals4
- Aug 11, 2023Granted 3,075 shares of Jazz Pharmaceuticals4
- Aug 8, 2022Sold 1,089 shares at $152.32 of Jazz Pharmaceuticals5
- Aug 5, 2022Granted 2,561 shares of Jazz Pharmaceuticals5
- May 9, 2022Sold 9 shares at $150.49 of Jazz Pharmaceuticals6
- May 9, 2022Sold 457 shares at $148.92 of Jazz Pharmaceuticals6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARJazz Pharmaceuticals, Board member
- 2
- 3SEC EDGARForm 4 filed Aug 6, 2024
- 4SEC EDGARForm 4 filed Aug 15, 2023
- 5SEC EDGARForm 4 filed Aug 9, 2022
- 6SEC EDGARForm 4 filed May 11, 2022